Kirk R. Daffner

Kirk R. Daffner

Auto-generated profile, based on publicly available information

Kirk R. Daffner

Center for Brain/Mind Medicine, Laboratory of Healthy Cognitive Aging, Department of Neurology, Brigham and Women's Hospital/Harvard Medical School, 60 Fenwood Road, Boston, MA, 02115, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in The American Journal of Medicine
Verified
Journal Article
Closed access
SGSeth Gale
Seth Gale
DADiler Acar
Diler Acar
KDKirk R. Daffner
Kirk R. Daffner

21 April 2021 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
PDF file
TKTaylor J. Krivanek
Taylor J. Krivanek
SGSeth A. Gale
Seth A. Gale
BMBrittany M. McFeeley
Brittany M. McFeeley
CNCasey M. Nicastri
Casey M. Nicastri
KDKirk R. Daffner
Kirk R. Daffner
A decade has passed since we published a comprehensive review in this journal addressing the topic of promoting successful cognitive aging, making this a good time to take stock of the field. Because there have been limited large-scale, randomized controlled trials, especially following individuals from middle age to late life, some experts have questioned whether recommendations can be legitimately offered about reducing the risk of cognitive decline and dementia. Despite uncertainties, clinicians often need to at least make provisional recommendations to patients based on the highest quality data available. Converging lines of evidence from epidemiological/cohort studies, animal/basic science studies, human proof-of-concept studies, and human intervention studies can provide guidance, highlighting strategies for enhancing cognitive reserve and preventing loss of cognitive capacity. Many of the suggestions made in 2010 have been supported by additional research. Importantly, there is a growing consensus among major health organizations about recommendations to mitigate cognitive decline and promote healthy cognitive aging. Regular physical activity and treatment of cardiovascular risk factors have been supported by all of these organizations. Most organizations have also embraced cognitively stimulating activities, a heart-healthy diet, smoking cessation, and countering metabolic syndrome. Other behaviors like regular social engagement, limiting alcohol use, stress management, getting adequate sleep, avoiding anticholinergic medications, addressing sensory deficits, and protecting the brain against physical and toxic damage also have been endorsed, although less consistently. In this update, we review the evidence for each of these recommendations and offer practical advice about behavior-change techniques to help patients adopt brain-healthy behaviors.

30 August 2022 in Alzheimer's & Dementia: Translational Research & Clinical Interventions
Verified
Journal Article
Open access
CNCasey M. Nicastri
Casey M. Nicastri
BMBrittany M. McFeeley
Brittany M. McFeeley
SSSharon S. Simon
Sharon S. Simon
ALAurélie Ledreux
Aurélie Ledreux
KHKrister Håkansson
Krister Håkansson
KDKirk R. Daffner
Kirk R. Daffner
Introduction: The often‐cited mechanism linking brain‐derived neurotrophic factor (BDNF) to cognitive health has received limited experimental study. There is evidence that cognitive training, physical exercise, and mindfulness meditation may improve cognition. Here, we investigated whether improvements in cognition after these three types of structured interventions are facilitated by increases in BDNF. Methods: A total of 144 heathy older adults completed a 5‐week intervention involving working memory/cognitive training, physical exercise, mindfulness meditation, or an active control condition. Serum BDNF levels and Digit Symbol Test (DST) performance were measured pre‐ and post‐intervention. Results: Linear mixed models suggested that only the cognitive training group demonstrated augmentation of BDNF and DST performance relative to the control condition. Path analysis revealed that changes in BDNF mediate intervention‐related improvement in task performance. Regression analyses showed that, across all intervention conditions, increased BDNF levels were associated with increased DST scores. Discussion: This study appears to be the first to suggest that BDNF helps mediate improvements in cognition after working memory training in healthy older adults. Highlights: Older adults were randomized to physical activity, mindfulness, cognitive training (computerized cognitive training (CCT), or control. CCT, but no other condition, led to increased serum brain‐derived neurotrophic factor (BDNF) levels. CCT led to improvement on the untrained Digit Symbol Test (DST) of speed/working memory. Path analysis: increases in BDNF mediate intervention‐related improvement on DST. Increases in BDNF associated with improved DST across all experimental groups.

2 August 2018 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
SSSharon S Simon
Sharon S Simon
ETErich S Tusch
Erich S Tusch
NFNicole C Feng
Nicole C Feng
KHKrister Håkansson
Krister Håkansson
AMAbdul H Mohammed
Abdul H Mohammed
KDKirk R Daffner
Kirk R Daffner
Background: Developing effective interventions to attenuate age-related cognitive decline and prevent or delay the onset of dementia are major public health goals. Computerized cognitive training (CCT) has been marketed increasingly to older adults, but its efficacy remains unclear. Working memory (WM), a key determinant of higher order cognitive abilities, is susceptible to age-related decline and a relevant target for CCT in elders. Objective: To evaluate the efficacy of CCT focused on WM compared to an active control condition in healthy older adults. Methods: Eighty-two cognitively normal adults from two sites (USA and Sweden) were randomly assigned to Cogmed Adaptive or Non-Adaptive (active control) CCT groups. Training was performed in participants’ homes, five days per week over five weeks. Changes in the performance of the Cogmed trained tasks, and in five neuropsychological tests (Trail Making Test Part A and Part B, Digit Symbol, Controlled Oral Word Association Test and Semantic Fluency) were used as outcome measures. Results: The groups were comparable at baseline. The Adaptive group showed robust gains in the trained tasks, and there was a time-by-group interaction for the Digit Symbol test, with significant improvement only after Adaptive training. In addition, the magnitude of the intervention effect was similar at both sites. Conclusion: Home-based CCT Adaptive WM training appears more effective than Non-Adaptive training in older adults from different cultural backgrounds. We present evidence of improvement in trained tasks and on a demanding untrained task dependent upon WM and processing speed. The benefits over the active control group suggest that the Adaptive CCT gains were linked to providing a continuously challenging level of WM difficulty.

1 January 2012 in Frontiers in Human Neuroscience
Verified
Journal Article
Open access
KDKirk R. Daffner
Kirk R. Daffner
ETElise C. Tarbi
Elise C. Tarbi
AHAnna E. Haring
Anna E. Haring
TZTatyana Y. Zhuravleva
Tatyana Y. Zhuravleva
XSXue Sun
Xue Sun
PHPhillip J. Holcomb
Phillip J. Holcomb
Recent investigations that suggest selective attention is dependent on top-down control mechanisms lead to the expectation that individuals with high executive capacity would exhibit more robust neural indices of selective attention. This prediction was tested by using event-related potentials (ERPs) to examine differences in markers of information processing across 25 subjects divided into 2 groups based on high vs. average executive capacity, as defined by neuropsychological test scores. Subjects performed an experimental task requiring selective attention to a specified color. In contrast to expectation, individuals with high and average executive capacity did not differ in the size of ERP indices of selective attention: the anterior Selection Positivity (SP) and posterior Selection Negativity (SN). However, there were substantial differences between groups in markers of subsequent processing, including the anterior N2 (a measure of attentional control) and the P3a (an index of the orienting of attention). Executive capacity predicted speed of processing at both early and late attentional stages. Individuals with lower executive capacity exhibited prolonged SN, P3a, and P3b latencies. However, the delays in carrying out selective attention operations did not account for subsequent delays in decision making, or explain excessive orienting and reduced attentional control mechanisms in response to stimuli that should have been ignored. SN latency, P3 latency, and the size of the anterior N2 made independent contributions to the variance of executive capacity. In summary, our findings suggest that current views regarding the relationship between top-down control mechanisms and selective attention may need refinement.

1 April 2021 in Neurology Clinical Practice
Verified
Journal Article
Open access
PDF file
GDGayatri Devi
Gayatri Devi
DGDarren Gitelman
Darren Gitelman
DPDaniel Press
Daniel Press
KDKirk R. Daffner
Kirk R. Daffner
Aging physicians are at a higher risk of cognitive impairment, undermining patient safety and unraveling physicians9 careers. Neurologists, occupational health physicians, and psychiatrists will participate in both health system policy decisions and individual patient evaluations. We address cognitive impairment in aging physicians and attendant risks and benefits. If significant cognitive impairment is found after an appropriate evaluation, precautions to confidentially support physicians9 practicing safely for as long as possible should be instituted. Understanding that there is heterogeneity and variability in the course of cognitive disorders is crucial to supporting cognitively impaired, practicing physicians. Physicians who are no longer able to practice clinically have other meaningful options.